Hormonal
GLP-1 receptor agonists provide renoprotective effects by slowing eGFR decline and reducing albuminuria in patients with type 2 diabetes and chronic kidney disease.
If you have diabetes and kidney issues, GLP-1 medications can help protect your kidneys and heart, not just your blood sugar. This protection happens through multiple mechanisms, including reducing inflammation and improving blood flow to the kidneys. However, gastrointestinal side effects are common and may require dose adjustments or management strategies.
The FLOW trial... established that semaglutide had direct renoprotective effects that lowered the risk of kidney and heart-related death.
Why this rating
Supported by the FLOW trial, a major outcome trial cited in the text.
Source
GLP-1 Receptor Agonists: Advances in Mechanism, Therapeutic Applications, and Future Perspectives
Megha Pawar et al. · BioMed Target Journal · 2025
DOI 10.59786/bmtj.322
More from this paper
- GLP-1 receptor agonists (e.g., semaglutide 2.4 mg) produce clinically significant weight loss and reduce major adverse cardiovascular events (MACE) in adults with obesity or overweight, regardless of diabetes status.Strong
- Dual and triple incretin agonists (e.g., tirzepatide, retatrutide) offer superior weight loss and glycemic control compared to single GLP-1 agonists.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →